GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (XCNQ:DOSE) » Definitions » Institutional Ownership

Rapid Dose Therapeutics (XCNQ:DOSE) Institutional Ownership : 0.54% (As of Sep. 20, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Rapid Dose Therapeutics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Rapid Dose Therapeutics's institutional ownership is 0.54%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Rapid Dose Therapeutics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Rapid Dose Therapeutics's Float Percentage Of Total Shares Outstanding is 0.00%.


Rapid Dose Therapeutics Institutional Ownership Historical Data

The historical data trend for Rapid Dose Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Institutional Ownership Chart

Rapid Dose Therapeutics Historical Data

The historical data trend for Rapid Dose Therapeutics can be seen below:

2020-05-31 2020-06-30 2020-07-31 2020-08-31 2020-09-30 2020-10-31 2020-11-30 2020-12-31 2021-01-31 2021-02-28
Institutional Ownership 1.19 0.57 0.57 0.57 0.57 0.57 0.57 0.57 0.57 0.54

Rapid Dose Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Rapid Dose Therapeutics Business Description

Traded in Other Exchanges
Address
1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.
Executives
Brian Howlett Director

Rapid Dose Therapeutics Headlines

No Headlines